Fpm. O'Harte et al., Structure, antihyperglycemic activity and cellular actions of a novel diglycated human insulin, PEPTIDES, 21(10), 2000, pp. 1519-1526
Human insulin was glycated under hyperglycemic reducing conditions and a no
vel diglycated form (M-r 6135.1 Da) was purified by RP-HPLC. Endoproteinase
Glu-C digestion combined with mass spectrometry and automated Edman degrad
ation localized glycation to Gly(1) and Phe(1) of the insulin A- and B-chai
ns, respectively. Intraperitoneal (i.p.) administration of diglycated insul
in to mice alone or in combination with glucose (7 nmol/kg) resulted in a 4
3-61% and 11-34% reduction in glucose lowering activity, respectively, comp
ared with native insulin. Consistent with these findings, diglycated insuli
n (10(-9) to 10(-7) mol/liter) was 22-38% less effective (P < 0.001) than n
ative insulin in stimulating glucose uptake, glucose oxidation and glycogen
production in isolated mouse abdominal muscle. (C) 2000 Elsevier Science I
nc. All rights reserved.